The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin

Endocrinology
Marilyn H PerrinWylie W Vale

Abstract

The CRF receptors are members of a 7-transmembrane receptor family that includes GH-releasing hormone (GRF), calcitonin, vasoactive intestinal peptide (VIP), secretin, and PTH receptors. To determine the structural features of the CRF receptor that may influence ligand recognition, a series of mutant receptors was analyzed for binding to astressin, a CRF antagonist, and to urocortin, a CRF agonist. Mutant receptors included chimeras between the CRF-R1 and GRF-R or Activin IIB-R, a single membrane spanning receptor serine/threonine kinase. Binding to the mutant receptors was assessed using 125I-[DTyr1] astressin (Ast*) and 125I-[Tyr0]-rat urocortin (Ucn*). There was no binding to a chimeric receptor in which the first extracellular domain (E1c) (i.e. the N-terminal region) of the CRF-R1 was replaced by that of the GRF-R. The complementary chimera in which E1 domain of the GRF-R was replaced by that of the CRF-R1 bound astressin and urocortin with Ki values approximately 10 nM, compared with inhibitory binding dissociation constant (Ki) values of approximately 2-4 nM for the wild-type CRF-R1. The chimera in which E1 of the activin IIB receptor was replaced by E1 of the CRF-R1 bound astressin with a Ki approximately 4 nM. A chimer...Continue Reading

References

Sep 1, 1980·Analytical Biochemistry·P J Munson, D Rodbard
Nov 7, 1995·Proceedings of the National Academy of Sciences of the United States of America·J GulyasJ Rivier
May 1, 1995·Trends in Pharmacological Sciences·G B Smith, R W Olsen
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R ChenW W Vale
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·M PerrinW Vale
Feb 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·T KishimotoM G Rosenfeld
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·T W LovenbergT Oltersdorf
Jan 1, 1994·Annual Review of Biochemistry·C D StraderR A Dixon
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·E PotterW Vale
Apr 4, 1996·European Journal of Pharmacology·X LiH I Yamamura

❮ Previous
Next ❯

Citations

Aug 25, 2004·Proceedings of the National Academy of Sciences of the United States of America·Christy R R GraceRoland Riek
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Christy Rani R GraceRoland Riek
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·F M DautzenbergJ Spiess
Aug 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·S M NielsenW W Vale
Sep 20, 2008·The Journal of Biological Chemistry·Augen A PioszakH Eric Xu
Oct 29, 2008·The Journal of Biological Chemistry·Iman Assil-KishawiAbdul B Abou-Samra
Sep 22, 2001·Protein Science : a Publication of the Protein Society·B A HofmannJ Spiess
Feb 6, 2010·European Journal of Pharmacology·Li-Zhen YangJoachim Spiess
Jun 13, 2002·The Journal of Investigative Dermatology·Alexander Pisarchik, Andrzej Slominski
Nov 7, 2006·Frontiers in Neuroendocrinology·Eva M Fekete, Eric P Zorrilla
Jun 23, 2004·European Journal of Biochemistry·Alexander Pisarchik, Andrzej Slominski
Sep 3, 2011·British Journal of Pharmacology·Dimitris K Grammatopoulos
Oct 13, 2004·Peptides·Pasquale FlorioFelice Petraglia
Jun 22, 1999·General and Comparative Endocrinology·D A Lovejoy, R J Balment
Dec 7, 2010·General and Comparative Endocrinology·Rajeev Singh, Umesh Rai
Aug 16, 2018·Physiological Reviews·Jan M Deussing, Alon Chen
Sep 19, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dimitri E GrigoriadisJohn A Williams
Apr 13, 1999·The Journal of Clinical Endocrinology and Metabolism·F PetragliaW Vale
Oct 19, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A Pisarchik, A T Slominski
Oct 21, 2015·Hormone Molecular Biology and Clinical Investigation·David A Lovejoy, Téa Pavlović
May 19, 2000·Annals of the New York Academy of Sciences·M H Perrin, W W Vale
Dec 20, 2002·Biopolymers·Cecilia G Unson
Jun 3, 2018·Hormones : International Journal of Endocrinology and Metabolism·Vlasios KarageorgosGeorge Liapakis
Oct 12, 2001·American Journal of Physiology. Endocrinology and Metabolism·I Q Assil, A B Abou-Samra
Feb 22, 2000·The Journal of Biological Chemistry·M BeyermannM Bienert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.